Iteos Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Iteos Therapeutics Inc
TickerITOS
CIK #0001808865
CUSIP46565G104
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address139 Main Street, Cambridge, MA 02142
Source [EDGAR]
CIK Filing 2011 - 2024
[0001808865] 10-K
[0001808865] 10-Q
[0001808865] 3
[0001808865] 4
[0001808865] 5
[0001808865] 8-K
[0001808865] D
[0001808865] SC 13D
[0001808865] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Vanguard Group Inc Iteos Therapeutics Inc [2023-02-09] 5.11
BlackRock Inc Iteos Therapeutics Inc [2022-07-08] 10.5
Biotechnology Value Fund L P Iteos Therapeutics Inc [2022-05-02] 2.9
Janus Henderson Group PLC Iteos Therapeutics Inc [2021-02-12] 5.7
RTW Investments LP Iteos Therapeutics Inc [2021-02-04] 7.88
MPM BioVentures 2014 LP Iteos Therapeutics Inc [2020-08-07] 6.2
Boxer Capital LLC Iteos Therapeutics Inc [2020-08-07] 13.0
RA Capital Management LP Iteos Therapeutics Inc [2020-08-05] 13.2
Form 3/4/5 Filer 2011 - 2024
Call Matthew
iTeos Therapeutics, Inc.
Lager Joanne Jenkins
McGrath Yvonne
Detheux Michel
Gall Matthew
DiRocco Derek
Davis Aaron I.
Biniszkiewicz Detlev
Iannone Robert
RA Capital Healthcare Fund LP
RA Capital Management LP
Shah Rajeev M.
Kolchinsky Peter
Van Hauwermeiren Timothy
Roden Matthew
Rhoads Ann D
Ho Tony W
Hallal David
Boxer Capital, LLC
Boxer Asset Management Inc.
Lewis Joseph
BioImpact Capital LLC
UBS Oncology Impact Fund L.P.
Gadicke Ansbert
Oncology Impact Fund (Cayman) Management L.P.
Evnin Luke
MPM BioVentures 2014 LLC
MPM BioVentures 2014, L.P.
MPM BioVentures 2018 B LP
MPM BioVentures 2014 (B), L.P.
MPM BioVentures 2014 GP LLC
MPM Asset Management Investors Bv2018 LLC
MPM Asset Management Investors BV2014 LLC
Foley Todd
MPM BioVentures 2018 LLC
MPM BioVentures 2018 LP
MPM BioVentures 2018 GP LLC
MVA Investors, LLC
MPM Oncology Impact Management GP LLC
Belawat Priyanka
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock Inc. [2023-03-31] SOLE 4,387,267.0 4,463,306.0
RA Capital Management LP [2023-03-31] SOLE 0.0 4,417,259.0
MPM Asset Management LLC [2023-03-31] SOLE 2,738,785.0 2,738,785.0
Boxer Capital, LLC [2023-03-31] OTR 2,154,058.0 2,154,058.0
State Street Corp [2023-03-31] DFND 1,792,291.0 1,827,391.0
BVF Inc/IL [2023-03-31] DFND 0.0 1,810,835.0
Bioimpact Capital LLC [2023-03-31] SOLE 1,745,943.0 1,745,943.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 1,736,793.0
Citadel Advisors LLC [2023-03-31] DFND 1,458,600.0 1,458,600.0
Candriam SCA [2023-03-31] SOLE 739,485.0 739,485.0
Octagon Capital Advisors LP [2023-03-31] SOLE 596,000.0 596,000.0
Invesco Ltd. [2023-03-31] DFND 0.0 588,561.0
Morgan Stanley [2023-03-31] DFND 519,253.0 563,214.0
Millennium Management LLC [2023-03-31] SOLE 528,272.0 528,272.0
JPMorgan Chase & Co [2023-03-31] DFND 442,363.0 526,157.0
Jacobs Levy Equity Management Inc [2023-03-31] SOLE 449,519.0 514,925.0
Geode Capital Management LLC [2023-03-31] DFND 481,239.0 481,239.0
Saturn V Capital Management LLC [2023-03-31] SOLE 480,653.0 480,653.0
683 Capital Management LLC [2023-03-31] DFND 480,000.0 480,000.0
Goldman Sachs Group Inc [2023-03-31] DFND 438,109.0 438,109.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 391,597.0 400,255.0
Artal Group S.A. [2023-03-31] DFND 400,000.0 400,000.0
Renaissance Technologies LLC [2023-03-31] SOLE 329,900.0 329,900.0
Citigroup Inc [2023-03-31] DFND 288,885.0 288,885.0
Bridgeway Capital Management LLC [2023-03-31] SOLE 266,945.0 266,945.0
Bank of New York Mellon Corp [2023-03-31] DFND 248,472.0 261,955.0
Barclays PLC [2023-03-31] SOLE 256,956.0 256,956.0
Northern Trust Corp [2023-03-31] DFND 9,267.0 251,704.0
AXA Sa [2023-03-31] DFND 218,600.0 218,600.0
Tang Capital Management LLC [2023-03-31] OTR 0.0 216,700.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com